29
1977
Short- and long-term mechanisms of tau regulation in PC12 cells.

Jacob Barg , Einat Sadot , Irith Ginzburg , David Rasouly
Journal of Cell Science 108 ( 8) 2857 -2864

27
1995
Electrospun hydroxyapatite-containing chitosan nanofibers crosslinked with genipin for bone tissue engineering

Michael E. Frohbergh , Anna Katsman , Gregory P. Botta , Phillip Lazarovici
Biomaterials 33 ( 36) 9167 -9178

395
2012
Secretory Systems and Toxins

Michal Linial , Alfonso Grasso , Phillip Lazarovici ,
Smpte Journal

2003
VESICULAR TRAFFICKING ON THE LATE SECRETORY PATHWAY IN THE BUDDING YEAST, S. CEREVISIAE

Michal Linial , Alfonso Grasso , Phillip Lazarovici
CRC Press 99 -128

2003
Nerve Growth Factor (NGF) and Its Receptors in Skeletal Muscle Signaling

Philip Lazarovici , Keren Ettinger , Yoram Nevo , Cezary Marcinkiewicz
The FASEB Journal 25

2011
Dr. Gordon Guroff (1933–1999)

Philip Lazarovici
Journal of Molecular Neuroscience 14 ( 1) 1 -2

1
2000
Rasagiline – a novel MAO B inhibitor in Parkinson’s disease therapy

Shimon Lecht , Philip Lazarovici , Simon Haroutiunian , Amnon Hoffman
Therapeutics and Clinical Risk Management 3 ( 3) 467 -474

38
2007
Chimeric Toxins : Mechanisms of Action and Therapeutic Applications

Haya Lorberboum-Galski , Philip Lazarovici
CRC Press

3
2002
Involvement of Extracellular Signal-Regulated Kinase (ERK) in Pardaxin-Induced Dopamine Release from PC12 Cells

Eugenia Bloch-Shilderman , Philip Lazarovici , Saleh Abu-Raya , Michal Linial
Journal of Pharmacology and Experimental Therapeutics 296 ( 3) 704 -711

24
2001
Characterization of Pardaxin-Induced Dopamine Release from Pheochromocytoma Cells: Role of Calcium and Eicosanoids

Peter I. Lelkes , Esther Shohami , Eugenia Bloch-Shilderman , Philip Lazarovici
Journal of Pharmacology and Experimental Therapeutics 288 ( 2) 399 -406

19
1999
Pardaxin, a New Pharmacological Tool to Stimulate the Arachidonic Acid Cascade in PC12 Cells

Esther Shohami , Eugenia Bloch-Shilderman , Philip Lazarovici , Victoria Trembovler
Journal of Pharmacology and Experimental Therapeutics 287 ( 3) 889 -896

17
1998
Tamoxifen inhibits nerve growth factor-induced proliferation of the human breast cancerous cell line MCF-7.

Laurence Lempereur , Philip Lazarovici , Renato Bernardini , Andrea Chiarenza
Cancer Research 61 ( 7) 3002 -3008

72
2001
Expression Levels of the Nerve Growth Factor Receptors TrkA and p75 in Effusions and Solid Tumors of Serous Ovarian Carcinoma Patients

Mariusz Goscinski , Philip Lazarovici , Reuven Reich , Gregg van de Putte
Clinical Cancer Research 7 ( 11) 3457 -3464

53
2001
Neuroprotection by human umbilical cord blood- derived progenitors in ischemic brain injuries

Shimon Lecht , Philip Lazarovici , Hadar Arien-Zakay , Hadar Arien-Zakay
Archives Italiennes De Biologie 149 ( 2) 233 -245

19
2011
Expression and Activation of the Nerve Growth Factor Receptor TrkA in Serous Ovarian Carcinoma

Philip Lazarovici , Vivi Ann Flørenes , Reuven Reich , Björn Risberg
Clinical Cancer Research 9 ( 6) 2248 -2259

149
2003
Phospholipases and direct lytic factors derived from the venom of the scorpion Scorpio Maurus Palmatus (scorpionidae)

M Menashe , E. Zlotkin , David Lester , Y Hochman
Israel Journal of Zoology 30 112 -112

1
1981
Pardaxin, an ionophore neurotoxin, induces PC12 cell death: activation of stress kinases and production of reactive oxygen species.

Eugenia Bloch-Shilderman , Philip Lazarovici , Hao Jiang
Journal of Natural Toxins 11 ( 2) 71 -85

11
2002
1
2002